FDA warns Amazon again for selling unapproved drugs online

01 Nov 2022
endpts.com
Slowly but surely the FDA is cracking down on the vast, illegal online sale of drugs made possible by behemoths like Amazon. In a warning letter dated Oct. 28, the FDA told Amazon CEO Andy Jassy that the company sold and distributed drugs with undeclared active ingredients that were marketed as dietary supplements. The FDA said it confirmed via lab analyses that the “Artri Ajo King,” “Ortiga Mas Ajo Rey,” and “Artri King Reforzado con Ortiga y Omega 3” purchased on Amazon.com contained the API of the NSAID pain drug diclofenac, which is not listed on the product labels. The letter follows a notice from last January in which the FDA warned the public not to purchase these products, which are promoted and sold for joint pain and arthritis. The FDA wrote at the time: The FDA ran additional lab analyses revealing in April that certain Artri and Ortiga products also contained dexamethasone, a corticosteroid, and the muscle relaxant methocarbamol, which can cause sedation, dizziness and low blood pressure. And in an update on its January warning, the agency said it has received adverse event reports linked to these Artri King products, including of liver toxicity and death, since the agency issued its first warning. This is the second time this year that the FDA has sent a warning letter to Jassy, with the first coming in August for selling mole removal products over-the-counter even though they were unapproved products. In both cases, the FDA purchased the drugs from Amazon.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.